Other authors [8, 9] have suggested that CA-125 immunoreactivity in the presence of an elevated serum CA-125 level could be a useful tumor marker for the diagnosis of ES and for monitoring the clinical course of patients with ES. This evidence concerns the gene MUC16 and neoplasm.